Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.37 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2137103 | 1.00 | CA1 (0.45) | CA1CA2CA12CA7CA9 | |
| SCHEMBL30579954 | 1.00 | CA1 (0.45) | CA1CA2CA12CA7CA9 | |
| SCHEMBL252044 | 0.85 | ALDH1A1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL30379901 | 0.85 | ALDH1A1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL31525792 | 0.84 | CA1 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL799917 | 0.84 | CA1 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9167803 | 0.83 | CYP1A2 (0.43) | CA1CA2CA12CA7CA9 | |
| SCHEMBL22140241 | 0.80 | CA1 (0.44) | CA1CA2CA12CA7CA9 | |
| Hydrochloric Acid SCHEMBL27479241 | 0.78 | CA1 (0.45) | CA1CA2CA12CA7CA9 | |
| SCHEMBL13839503 | 0.77 | LPAR1 (0.48) | ALDH1A1GAALPAR1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304516-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, ULTRAVIOLET-CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANEDIMETHANOL COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4617255-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, UV-CURABLE COMPOSITION, POLYMER COMPOSITION, AND TRICYCLODECANEDIMETHANOL COMPOSITION PRODUCTION METHOD | Mitsubishi Chemical Corporation (JP) | 2025-09-17 | — | — | EP | disclosed |
| EP-3696160-B1 | EXTRACTION PROCESS FOR HIGH-BOILING ALDEHYDE PRODUCT SEPARATION AND CATALYST RECOVERY | DAIREN CHEMICAL CORP (TW) | 2023-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304516-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, ULTRAVIOLET-CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANEDIMETHANOL COMPOSITION | XPA, XPOT, ACMSD | CA1 2532/4885CA2 4712/4885CA12 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.